PL2477628T3 - Wytwarzanie krystalicznych hemihydratowych postaci dihydropirazolopirymidynonu - Google Patents
Wytwarzanie krystalicznych hemihydratowych postaci dihydropirazolopirymidynonuInfo
- Publication number
- PL2477628T3 PL2477628T3 PL10817669T PL10817669T PL2477628T3 PL 2477628 T3 PL2477628 T3 PL 2477628T3 PL 10817669 T PL10817669 T PL 10817669T PL 10817669 T PL10817669 T PL 10817669T PL 2477628 T3 PL2477628 T3 PL 2477628T3
- Authority
- PL
- Poland
- Prior art keywords
- dihydropyrazolopyrimidinone
- preparation
- crystalline hemihydrate
- hemihydrate forms
- forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24242809P | 2009-09-15 | 2009-09-15 | |
US32304510P | 2010-04-12 | 2010-04-12 | |
EP10817669.4A EP2477628B1 (en) | 2009-09-15 | 2010-09-02 | Preparation of crystalline hemihydrate forms of dihydropyrazolopyrimidinone |
PCT/US2010/047622 WO2011034743A1 (en) | 2009-09-15 | 2010-09-02 | Preparation of crystalline forms of dihydropyrazolopyrimidinone |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2477628T3 true PL2477628T3 (pl) | 2015-02-27 |
Family
ID=43758964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10817669T PL2477628T3 (pl) | 2009-09-15 | 2010-09-02 | Wytwarzanie krystalicznych hemihydratowych postaci dihydropirazolopirymidynonu |
Country Status (9)
Country | Link |
---|---|
US (2) | US8703779B2 (pl) |
EP (1) | EP2477628B1 (pl) |
DK (1) | DK2477628T3 (pl) |
ES (1) | ES2524161T3 (pl) |
HR (1) | HRP20140821T1 (pl) |
PL (1) | PL2477628T3 (pl) |
PT (1) | PT2477628E (pl) |
SI (1) | SI2477628T1 (pl) |
WO (1) | WO2011034743A1 (pl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013039854A1 (en) | 2011-09-15 | 2013-03-21 | Merck Sharp & Dohme Corp. | Compositions and methods for treating cancer |
PT2925888T (pt) * | 2012-11-28 | 2017-12-13 | Merck Sharp & Dohme | Composições e métodos para tratamento do cancro |
CN110198943B (zh) | 2017-01-23 | 2021-04-16 | 石家庄智康弘仁新药开发有限公司 | 作为Wee1抑制剂的1,2-二氢-3H-吡唑[3,4-d]嘧啶-3-酮衍生物 |
CN109422754A (zh) * | 2017-08-24 | 2019-03-05 | 上海迪诺医药科技有限公司 | 吡唑并[3,4-d]嘧啶-3-酮衍生物、其药物组合物及应用 |
EP3694861A4 (en) * | 2017-10-09 | 2021-05-19 | Nuvation Bio Inc. | HETEROCYCLIC COMPOUNDS AND THEIR USES |
CA3078945A1 (en) | 2017-10-09 | 2019-04-18 | Nuvation Bo Inc. | Heterocyclic compounds and uses thereof |
BR112020008664A8 (pt) | 2017-11-01 | 2023-01-17 | Shijiazhuang Sagacity New Drug Dev Co Ltd | Composto macrocíclico que atua como inibidor de weel e aplicações do mesmo |
JP7481336B2 (ja) | 2018-10-26 | 2024-05-10 | ウーシー・バイオシティ・バイオファーマシューティクス・カンパニー・リミテッド | Wee1阻害剤としてのピリミドピラゾロン類誘導体及びその使用 |
WO2020210375A1 (en) | 2019-04-09 | 2020-10-15 | Nuvation Bio Inc. | Heterocyclic compounds and uses thereof |
WO2020221358A1 (zh) | 2019-04-30 | 2020-11-05 | 石家庄智康弘仁新药开发有限公司 | Wee1抑制剂化合物的晶型及其应用 |
WO2021078925A1 (en) | 2019-10-25 | 2021-04-29 | Astrazeneca Ab | Methods of treating cancer |
EP4069224A4 (en) * | 2019-12-20 | 2023-12-20 | Recurium IP Holdings, LLC | ASSOCIATIONS |
JP2023508331A (ja) * | 2019-12-20 | 2023-03-02 | リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー | 組み合わせ |
WO2021254389A1 (zh) | 2020-06-17 | 2021-12-23 | 微境生物医药科技(上海)有限公司 | 作为Wee-1抑制剂的吡唑并[3,4-d]嘧啶-3-酮衍生物 |
WO2022228511A1 (zh) | 2021-04-30 | 2022-11-03 | 微境生物医药科技(上海)有限公司 | 作为Wee-1抑制剂的稠环化合物及其制备方法和用途 |
CN113735863A (zh) * | 2021-09-29 | 2021-12-03 | 武汉九州钰民医药科技有限公司 | Wee1抑制剂adavosertib的制备工艺 |
CN113880844B (zh) * | 2021-09-29 | 2023-02-14 | 武汉九州钰民医药科技有限公司 | Wee1蛋白激酶抑制剂adavosertib的化学合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003224341A1 (en) | 2002-04-26 | 2003-11-10 | Warner-Lambert Company Llc | Inhibitors of checkpoint kinases (wee1 and chk1) |
PE20080695A1 (es) | 2006-04-27 | 2008-06-28 | Banyu Pharma Co Ltd | Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel |
JP5411847B2 (ja) | 2007-04-25 | 2014-02-12 | Msd株式会社 | Weelキナーゼインヒビターとしてのジヒドロピラゾロピリミジノン誘導体の多形 |
-
2010
- 2010-09-02 SI SI201030764T patent/SI2477628T1/sl unknown
- 2010-09-02 ES ES10817669.4T patent/ES2524161T3/es active Active
- 2010-09-02 WO PCT/US2010/047622 patent/WO2011034743A1/en active Application Filing
- 2010-09-02 US US13/496,014 patent/US8703779B2/en active Active
- 2010-09-02 DK DK10817669.4T patent/DK2477628T3/en active
- 2010-09-02 EP EP10817669.4A patent/EP2477628B1/en active Active
- 2010-09-02 PT PT108176694T patent/PT2477628E/pt unknown
- 2010-09-02 PL PL10817669T patent/PL2477628T3/pl unknown
-
2014
- 2014-03-06 US US14/199,653 patent/US9388186B2/en active Active
- 2014-09-01 HR HRP20140821AT patent/HRP20140821T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20140821T1 (hr) | 2014-10-10 |
US20120172370A1 (en) | 2012-07-05 |
DK2477628T3 (en) | 2014-11-24 |
US20140187562A1 (en) | 2014-07-03 |
EP2477628A4 (en) | 2013-04-17 |
ES2524161T3 (es) | 2014-12-04 |
PT2477628E (pt) | 2014-11-25 |
EP2477628A1 (en) | 2012-07-25 |
EP2477628B1 (en) | 2014-08-20 |
WO2011034743A1 (en) | 2011-03-24 |
US8703779B2 (en) | 2014-04-22 |
US9388186B2 (en) | 2016-07-12 |
SI2477628T1 (sl) | 2014-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1254977A1 (zh) | 索非布韋(sofosbuvir)的結晶形式 | |
PT2477628E (pt) | Preparação de formas de hemihidrato cristalino de dihidropirazolopirimidinona | |
IL216648A0 (en) | Crystalline forms of febuxostat | |
EP2459011A4 (en) | PREPARATION OF HIGH-PURITY COLLAGEN | |
IL209196A (en) | A crystalline form of posaconazole | |
PL2401244T3 (pl) | Sposoby produkcji ceramicznych struktur | |
EP2407461A4 (en) | PROCESS FOR PREPARING 1-ALKYL-5-BENZOYL-1H-TETRAZOL DERIVATIVES | |
EP2424845A4 (en) | PREPARATION OF DECITABIN | |
HK1164698A1 (en) | Crystalline forms of genistein | |
ZA201202097B (en) | Crystalline forms of substituted pyrazolopyrimidines | |
ZA201204108B (en) | Crystalline forms of bosentan salts and processes for their preparation | |
ZA201109045B (en) | Crystalline form of pemirolast | |
GB0908711D0 (en) | Preparation of labelled compounds | |
GB0922023D0 (en) | Preparation of n-monofluoroalkyl compounds | |
PT2655363T (pt) | Formas cristalinas e processos para a sua preparação | |
IL205857A0 (en) | Processes for preparation of crystalline tigecyclline form ii | |
GB2470249B (en) | Preparation of coverings | |
EP2404891A4 (en) | PROCESS FOR THE PREPARATION OF ACYLBENZENES | |
EP2331490A4 (en) | PREPARATION OF DIBUTOXYMETHANE | |
EP2459540A4 (en) | PREPARATION OF FIPAMEZOLE | |
PL2408799T3 (pl) | Nowa krystaliczna postać anty-progesteronu CDB-4124 | |
GB201301307D0 (en) | Crystalline form of prulifloxacin and processes for its preparation | |
TWM372743U (en) | Improved structure of Kendama | |
TWM365675U (en) | Improved structure of teapoy | |
SI2398784T1 (sl) | Kristalna oblika febuksostata |